BLFSNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
BIOLIFE SOLUTIONS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$38.61+0.00 (0.00%)
Close on Oct 7, 2026
- Market cap
- $1.90B
- P/E (TTM)
- 33.6
- Dividend yield
- –
Dividends
Biolife Solutions has not reported a dividend
No dividend per share appears in Biolife Solutions's annual filings since fiscal 2010.